Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Brief summary (registry, in English)

The purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers. The study doctors want to compare more frequent monitoring versus less frequent monitoring as well as identify biomarkers which may improve risk detection of transformation to pancreatic cancer. The study doctors want to learn which monitoring method and which biomarkers lead to better outcomes for patients.

What you commit to

• Study type: Observational
• Planned participants: 770
• From 16 Jun 2020 to the primary completion date, 11 Nov 2034
• 429 sites in 4 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 50 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (429)

Sites in registry order. Pick your city on the disease page to sort them by distance.